<DOC>
	<DOC>NCT01827293</DOC>
	<brief_summary>This study was a prospective, randomized, double-blind, parallel group clinical trial designed to compare the efficacy of intravenous (IV) promethazine and lorazepam for the treatment of peripheral vertigo in Emergency Department setting.</brief_summary>
	<brief_title>Promethazine vs. Lorazepam for Treatment of Vertigo</brief_title>
	<detailed_description />
	<mesh_term>Vertigo</mesh_term>
	<mesh_term>Dizziness</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<criteria>Aged 18 years or older Background history of positional vertigo Unable to provide informed consent Pregnant or possibly pregnant Known allergy to study medications Use of antiemetic agents in the previous 24 hours Evidence of druginduced vertigo or orthostatic hypotension Central pathologies/central origin for vertigo</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>